Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX

Gibson Christopher sold 40,000 Recursion Pharmaceuticals, Inc. shares (Form 4)

Traded May 7, 2026 · Filed May 8, 2026

On May 7, 2026, Gibson Christopher (Director) sold 40,000 Recursion Pharmaceuticals, Inc. shares at US$3.37 for US$135K under a trading plan, leaving 906,556 shares. Filed May 8, 2026 (Form 4).

Sold
40,000 shares
Price
US$3.37
Value
US$135K
Holding after
906,556 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 7, 2026Class A Common StockConversion60,000966,556Direct
May 7, 2026Class A Common StockSale40,000US$3.37926,556Direct
May 7, 2026Class A Common StockGift20,000906,556Direct

Source

View original at SEC

Related